Skip to main content
. 2024 Oct 21;24:231. doi: 10.1186/s12894-024-01622-5

Table 1.

Patient characteristics

Variables Open
(N = 233)
Laparoscopy
(N = 415)
Robot
(N = 57)
p-value Missing data
N % N % N % N %
Gender
 Men 104 (45.2) 198 (47.7) 25 (43.9) 0.758
 Women 126 (54.8) 217 (52.3) 32 (56.1)
Age Mean ± SD 66.9 ± 10.9 70.1 ± 11.2 69.2 ± 10.5 0.003* 6 (2.15)
Laterality
 Left 104 (44.8) 207 (49.9) 28 (49.1) 0.490
 Right 124 (53.4) 204 (49.2) 28 (49.1)
 Bilateral 4 (1.7) 2 (0.5) 1 (1.8)
 Graft kidney 0 (0.0) 2 (0.5) 0 (0.0)
Tumor location
 Renal pelvis 159 (68.2) 302 (72.8) 45 (78.9) 0.214
 Upper ureter 46 (19.7) 111 (26.7) 9 (15.8) 0.046*
 Middle ureter 39 (16.7) 54 (13.0) 4 (7.0) 0.127
 Lower ureter 54 (23.2) 79 (19.0) 16 (28.1) 0.190
 Bladder cuff 3 (1.3) 19 (4.6) 1 (1.8) 0.062
Synchronous bladder tumor
 No 181 (78.7) 329 (79.9) 42 (75.0) 0.297 4 (1.43)
 Previous Hx of bladder UC 16 (7.0) 24 (5.8) 1 (1.8)
 Concurrent Bladder UC 33 (14.3) 59 (14.3) 13 (23.2)
Post operation intravesical C/T instillation 11 (3.94)
 No 215 (96.0) 364 (92.6) 46 (85.2) 0.015*
 Yes 9 (4.0) 29 (7.4) 8 (14.8)
Perioperative chemotherapy 2 (0.72)
 Neo-adjuvant 2 (0.9) 10 (2.4) 2 (3.5) 0.356
 Adjuvant 71 (30.5) 118 (28.4) 15 (26.3)
Adjuvant radiation therapy 12 (5.2) 25 (6.0) 1 (1.8) 0.154 2 (0.72)
Surgery
 Transperitoneal 56 (26.5) 208 (51.4) 47 (97.9) < 0.001*
 Retroperitoneal 155 (73.5) 197 (48.6) 1 (2.1)
Follow up (months) c median 14.68 28.55 18.86 < 0.001* 5 (1.79)